DENTSPLY SIRONA Inc. (XRAY)
NASDAQ: XRAY · Real-Time Price · USD
13.24
+0.08 (0.61%)
At close: Sep 22, 2025, 4:00 PM EDT
13.24
0.00 (0.00%)
After-hours: Sep 22, 2025, 5:57 PM EDT
DENTSPLY SIRONA Revenue
DENTSPLY SIRONA had revenue of $936.00M in the quarter ending June 30, 2025, a decrease of -4.88%. This brings the company's revenue in the last twelve months to $3.67B, down -5.78% year-over-year. In the year 2024, DENTSPLY SIRONA had annual revenue of $3.79B, down -4.34%.
Revenue (ttm)
$3.67B
Revenue Growth
-5.78%
P/S Ratio
0.72
Revenue / Employee
$262,214
Employees
14,000
Market Cap
2.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.79B | -172.00M | -4.34% |
| Dec 31, 2023 | 3.97B | 43.00M | 1.10% |
| Dec 31, 2022 | 3.92B | -309.00M | -7.30% |
| Dec 31, 2021 | 4.23B | 892.00M | 26.71% |
| Dec 31, 2020 | 3.34B | -683.00M | -16.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
XRAY News
- 13 days ago - DENTSPLY SIRONA Inc. (XRAY) Presents At Baird 2025 Global Healthcare Conference (Transcript) - Seeking Alpha
- 13 days ago - DENTSPLY SIRONA Inc. (XRAY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 14 days ago - Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives - GlobeNewsWire
- 18 days ago - Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 4% Dividend Yields - Benzinga
- 27 days ago - Dentsply Sirona to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
- 4 weeks ago - Dentsply Sirona: Turnaround Potential And Digital Workflows - Seeking Alpha
- 6 weeks ago - DENTSPLY SIRONA Inc. (XRAY) Q2 2025 Earnings Call Transcript - Seeking Alpha